Matches in SemOpenAlex for { <https://semopenalex.org/work/W4206126826> ?p ?o ?g. }
- W4206126826 abstract "Glutamine, like glucose, is a major nutrient consumed by cancer cells, yet these cells undergo glutamine starvation in the cores of tumors, forcing them to evolve adaptive metabolic responses. Pharmacologically targeting glutamine metabolism or withdrawal has been exploited for therapeutic purposes, but does not always induce cancer cell death. The mechanism by which cancer cells adapt to resist glutamine starvation in cisplatin-resistant non-small-cell lung cancer (NSCLC) also remains uncertain. Here, we report the potential metabolic vulnerabilities of A549/DDP (drug-resistant human lung adenocarcinoma cell lines) cells, which were more easily killed by the iron chelator deferoxamine (DFO) during glutamine deprivation than their parental cisplatin-sensitive A549 cells. We demonstrate that phenotype resistance to cisplatin is accompanied by adaptive responses during glutamine deprivation partly via higher levels of autophagic activity and apoptosis resistance characteristics. Moreover, this adaptation could be explained by sustained glucose instead of glutamine-dominant complex II-dependent oxidative phosphorylation (OXPHOS). Further investigation revealed that cisplatin-resistant cells sustain OXPHOS partly via iron metabolism reprogramming during glutamine deprivation. This reprogramming might be responsible for mitochondrial iron-sulfur [Fe-S] cluster biogenesis, which has become an “Achilles’ heel,” rendering cancer cells vulnerable to DFO-induced autophagic cell death and apoptosis through c-Jun N-terminal kinase (JNK) signaling. Finally, in vivo studies using xenograft mouse models also confirmed the growth-slowing effect of DFO. In summary, we have elucidated the adaptive responses of cisplatin-resistant NSCLC cells, which balanced stability and plasticity to overcome metabolic reprogramming and permitted them to survive under stress induced by chemotherapy or glutamine starvation. In addition, for the first time, we show that suppressing the growth of cisplatin-resistant NSCLC cells via iron chelator-induced autophagic cell death and apoptosis was possible with DFO treatment. These findings provide a solid basis for targeting mitochondria iron metabolism in cisplatin-resistant NSCLC for therapeutic purposes, and it is plausible to consider that DFO facilitates in the improvement of treatment responses in cisplatin-resistant NSCLC patients." @default.
- W4206126826 created "2022-01-26" @default.
- W4206126826 creator A5009788784 @default.
- W4206126826 creator A5013244136 @default.
- W4206126826 creator A5030968272 @default.
- W4206126826 creator A5032363532 @default.
- W4206126826 creator A5032911104 @default.
- W4206126826 creator A5037989560 @default.
- W4206126826 creator A5040461936 @default.
- W4206126826 creator A5042955432 @default.
- W4206126826 creator A5054229244 @default.
- W4206126826 creator A5060805738 @default.
- W4206126826 creator A5091378454 @default.
- W4206126826 date "2022-01-20" @default.
- W4206126826 modified "2023-10-14" @default.
- W4206126826 title "Deferoxamine Counteracts Cisplatin Resistance in A549 Lung Adenocarcinoma Cells by Increasing Vulnerability to Glutamine Deprivation-Induced Cell Death" @default.
- W4206126826 cites W1768966319 @default.
- W4206126826 cites W1891848729 @default.
- W4206126826 cites W1987604182 @default.
- W4206126826 cites W1987704691 @default.
- W4206126826 cites W2003921338 @default.
- W4206126826 cites W2005075246 @default.
- W4206126826 cites W2006774891 @default.
- W4206126826 cites W2011538447 @default.
- W4206126826 cites W2012326456 @default.
- W4206126826 cites W2019156893 @default.
- W4206126826 cites W2021975445 @default.
- W4206126826 cites W2038619536 @default.
- W4206126826 cites W2044414180 @default.
- W4206126826 cites W2057199368 @default.
- W4206126826 cites W2062107099 @default.
- W4206126826 cites W2063479802 @default.
- W4206126826 cites W2083248307 @default.
- W4206126826 cites W2083647969 @default.
- W4206126826 cites W2158380484 @default.
- W4206126826 cites W2164277862 @default.
- W4206126826 cites W2169187183 @default.
- W4206126826 cites W2174098335 @default.
- W4206126826 cites W2242964979 @default.
- W4206126826 cites W2285710263 @default.
- W4206126826 cites W2292613448 @default.
- W4206126826 cites W2314203155 @default.
- W4206126826 cites W2508132062 @default.
- W4206126826 cites W2603130010 @default.
- W4206126826 cites W2606441315 @default.
- W4206126826 cites W2747758951 @default.
- W4206126826 cites W2767169142 @default.
- W4206126826 cites W2768804672 @default.
- W4206126826 cites W2769335046 @default.
- W4206126826 cites W2782559169 @default.
- W4206126826 cites W2794637418 @default.
- W4206126826 cites W2796388989 @default.
- W4206126826 cites W2806785738 @default.
- W4206126826 cites W2917366261 @default.
- W4206126826 cites W2922415295 @default.
- W4206126826 cites W2957166771 @default.
- W4206126826 cites W2969391966 @default.
- W4206126826 cites W2969538494 @default.
- W4206126826 cites W2979654877 @default.
- W4206126826 cites W2980622391 @default.
- W4206126826 cites W3005857648 @default.
- W4206126826 cites W3036942667 @default.
- W4206126826 cites W3083837615 @default.
- W4206126826 cites W3108936441 @default.
- W4206126826 cites W3113203179 @default.
- W4206126826 cites W3116902555 @default.
- W4206126826 cites W3133660907 @default.
- W4206126826 cites W3146145140 @default.
- W4206126826 cites W3158318891 @default.
- W4206126826 cites W3160061374 @default.
- W4206126826 cites W3175730700 @default.
- W4206126826 cites W3177198110 @default.
- W4206126826 cites W3180723792 @default.
- W4206126826 cites W3182391099 @default.
- W4206126826 cites W3201657639 @default.
- W4206126826 cites W4231565327 @default.
- W4206126826 doi "https://doi.org/10.3389/fonc.2021.794735" @default.
- W4206126826 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35127502" @default.
- W4206126826 hasPublicationYear "2022" @default.
- W4206126826 type Work @default.
- W4206126826 citedByCount "3" @default.
- W4206126826 countsByYear W42061268262022 @default.
- W4206126826 countsByYear W42061268262023 @default.
- W4206126826 crossrefType "journal-article" @default.
- W4206126826 hasAuthorship W4206126826A5009788784 @default.
- W4206126826 hasAuthorship W4206126826A5013244136 @default.
- W4206126826 hasAuthorship W4206126826A5030968272 @default.
- W4206126826 hasAuthorship W4206126826A5032363532 @default.
- W4206126826 hasAuthorship W4206126826A5032911104 @default.
- W4206126826 hasAuthorship W4206126826A5037989560 @default.
- W4206126826 hasAuthorship W4206126826A5040461936 @default.
- W4206126826 hasAuthorship W4206126826A5042955432 @default.
- W4206126826 hasAuthorship W4206126826A5054229244 @default.
- W4206126826 hasAuthorship W4206126826A5060805738 @default.
- W4206126826 hasAuthorship W4206126826A5091378454 @default.
- W4206126826 hasBestOaLocation W42061268261 @default.
- W4206126826 hasConcept C121608353 @default.
- W4206126826 hasConcept C190283241 @default.
- W4206126826 hasConcept C203522944 @default.
- W4206126826 hasConcept C2776694085 @default.